Crohn Disease

Researchers examined the links between peripheral spondyloarthritis and Crohn disease, and how the gut microbiome can influence risk of the painful condition.

A recent placebo-controlled clinical trial tested the efficacy and safety of filgotinib in the treatment of patients with moderate to severe Crohn disease.

A new study examined the effect of a specific carbohydrate diet on fecal microbiome, and inflammatory bowel disease activity in children.

In a meta-analysis of 18 studies, researchers studied the relapse of patients with Crohn Disease after surgery.

Researchers compared the effects of various levels of dietary fiber intake on the risk of flares in Crohn disease and ulcerative colitis.

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.